Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results fromthe EPIC Clinical Trial.
Saved in:
| Title: | Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results fromthe EPIC Clinical Trial. |
|---|---|
| Authors: | Porter, John1 j.porter@ucl.ac.uk, Bowden, Donald K.2, Economou, Marina3, Troncy, Jacques4, Ganser, Arnold5, Habr, Dany6, Martin, Nicolas7, Gater, Adam8, Rofail, Diana8, Abetz-Webb, Linda8, Lau, Helen6, Cappellini, Maria Domenica9 |
| Source: | Anemia (20901267). 2012, p1-10. 10p. 2 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
